Medical Care Technologies Inc. Stocks

$ 0Last Updated 20.03.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

$ 1.47M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
$ 0
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Favourable price performance

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Medical Care Technologies Inc., a development stage company, engages in opening and operating children's integrated health and wellness centers in China. The company sells and distributes pharmaceutical and nutraceutical products, and other merchandise, including over-the-counter medicines, herbal products, personal care products, and family care products. It serves retail pharmacies, pharmaceutical companies, hospitals, physicians' office practices, and consumers; and industrial and food microbiology laboratories. The company offers its products through its pediatric health and wellness centers, Website, and retail pharmacies, as well as through sales and distribution channels, and directly to end-users through independent sales representatives. Medical Care Technologies Inc. was founded in 2007 and is headquartered in Beijing, China.

Company Valuation

Fairly valued
4/7

From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. In particular, the stock is overvalued on P/FCF.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks